ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SCLP Scancell Holdings Plc

9.65
-0.10 (-1.03%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -1.03% 9.65 9.30 10.00 9.75 9.65 9.75 542,863 10:14:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.48 89.53M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.75p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £89.53 million. Scancell has a price to earnings ratio (PE ratio) of -7.48.

Scancell Share Discussion Threads

Showing 13226 to 13243 of 67275 messages
Chat Pages: Latest  531  530  529  528  527  526  525  524  523  522  521  520  Older
DateSubjectAuthorDiscuss
12/1/2018
10:01
Iwo agema wars continues ....

(Iwo Jima)

inanaco
12/1/2018
09:54
Lozan called it right first time round valuing it at 47p

he has only traded twice in 5 years

Capital gone, profit gone ..... to feed the 26kw beast of a wood burner, a cloud of C02 hangs over Lozan Towers, walls crumble with acid rain

inanaco
12/1/2018
06:00
Seems like the ADVFN page this morning is as screwed up as are the LSE pages most days these days. Ithas reposted broadly what i had posted before.

A very poor post Lozan in any event, your problem is the share price hasn"t moved for any of the news. Only you can twist that, to everyone called it wrong. As you include me in your list of trypers, I don"t give share price predictions. I don"t believe anybody would have called the share price now after hearing he nes we have received. Except you of course, in retrospect as ever........lol.

chelsea35
12/1/2018
05:35
We are still in January, and for sure both announcements have been game changing, we have a clearer direction, with the realistic prospect of more to come. The market attributes no value to that, yet!! It will though IMHO
the real lozan11 Jan '18 - 14:46 - 13257 of 13257
0 1 0
The POINT Elsie is this - The CERTAINTY of a 'game-changing DEAL' being announced by the 'turn-over date of 10 Jan 2018' was being 'pushed' as 'bait for BUY, BUY, BUY ... and not OPEN to question by the trHYPERS { you included}

A very poor post Lozan, typical of all your retrospective efforts

chelsea35
11/1/2018
14:07
Lozan, I have posted many times the positives and negatives facing us this year, before the Moditope RNS. The SCIB2 RNS was more than half expected, the Moditope not so much, particularly in that indication.

We are still in January, and for sure both announcements have been game changing, we have a clearer direction, with the realistic prospect of more to come. The market attributes no value to that, yet!! It will though IMHO

chelsea35
11/1/2018
13:25
Thanks super.
gooosed
11/1/2018
13:21
gooosed - Cooley advised on the fund raising when Eversheds were still listed advisers. Took over some time after the end of May, don't know when exactly.
supernumerary
11/1/2018
13:06
Nothing has been ruled out by anybody, given the response to the share price after two very good RNSs. More importantly they are game changing, the first deals on both platforms and the promise "we are in talks with multiple companies" has indeed been confirmed and has been succesful. Given that, we can only decide whether more such RNSs will arrive in the short term.

I believe they will.

Lozan will always be right, shuffles the pack so many times, an irritant.

chelsea35
10/1/2018
22:30
Well spotted Gooosed ! Interesting
torquayfan
10/1/2018
20:48
ah good spot goosed!

Interesting, see that they're specialists in life sciences so looks like a sensible move, especially with the US bias.

bermudashorts
10/1/2018
20:24
There was a degree of speculation over the appointment of Eversheds as Scancells legal advisors.

Not sure when Cooley were engaged (perhaps someone can confirm) ?

Cooley (UK) LLP
Dashwood
69 Old Broad Street
London
EC2M 1QS

gooosed
10/1/2018
17:44
whats interesting ...

loz has only declared 2 trades which i have no issue with and seemed profitable which is great.

inanaco
10/1/2018
17:16
clearly that buy upsets you ... after all it might have gone down you did not know

47p .. as valued by Loz ...

nice one ...

inanaco
10/1/2018
15:49
P S
And YOU insist on speaking about "VALUE"
GUFFAW

the real lozan
10/1/2018
15:08
Lozan the thought of you dribbling over your Croissant's while trying to work out how you valued scancell at 47p ... makes all the faults of the LSE platform tolerable
inanaco
10/1/2018
13:26
LSE now up and 'running'
Leading Nappy to 'hot-foot' back to the relative safety of 'The Hole in the Wall-et Gang'

the real lozan
10/1/2018
12:58
or possibly less time wasted?
gazza
10/1/2018
12:57
Inan

Lol.

agema
Chat Pages: Latest  531  530  529  528  527  526  525  524  523  522  521  520  Older

Your Recent History

Delayed Upgrade Clock